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ABSTRACT
Tuberculosis is a serious health problem not only in Indonesia, but worldwide. Each year, it occurs in nearly 
9.7 million people and claims about 2 million lives worldwide. Pancreatic tuberculosis is a rare type of extra 
pulmonary tuberculosis that only occur less than 4.7% worldwide. The most common symptoms is abdominal 
pain and most of the patients shows abdominal tenderness on palpation. Diagnosis of pancreatic tuberculosis 
consist of tuberculin skin test, ultrasonography, computed tomography-scan, magnetic resonance imaging and 
biopsy. Diagnosing pancreatic tuberculosis is a challenge because of its rarity and it has similar symptoms as 
more common pancreatic condition such as pancreatic malignancy. Understanding of pancreatic tuberculosis 
will increased the clinical awareness that may guide clinicians to avoid unnecessary diagnostic or therapeutic 
procedures and early diagnosis. 
Keywords: tuberculosis, pancreatic tuberculosis, abdominal tuberculosis, abdominal pain
ABSTRAK
Tuberkulosis adalah masalah kesehatan serius dimana tidak hanya di Indonesia, tetapi di seluruh dunia. 
Setiap tahun, tuberkulosis terjadi pada hampir 9,7 juta orang dan menyebabkan kematian sekitar 2 juta jiwa di 
seluruh dunia. Tuberkulosis pankreas adalah jenis tuberkulosis ekstrapulmoner langka yang hanya terjadi kurang 
dari 4,7% di seluruh dunia. Gejala yang paling umum adalah nyeri perut dan sebagian besar pasien terdapat 
nyeri perut saat palpasi. Diagnosis tuberkulosis pankreas adalah dengan tes kulit tuberkulin, ulstrasonografi, 
computed-tomography scan, magnetic resonance imaging dan biopsi. Mendiagnosis tuberkulosis pankreas 
merupakan tantangan karena kelangkaannya dan memiliki gejala yang mirip dengan kondisi pankreas yang 
lebih umum seperti keganasan pankreas. Memahami tuberkulosis pankreas akan meningkatkan kewaspadaan 
klinis dokter untuk menghindari prosedur diagnostik atau terapeutik yang tidak perlu dan diagnosis dini.
Kata kunci: tuberkulosis, tuberkulosis pankreas, tuberkulosis abdomen, nyeri perut
INTRODUCTION 
Tuberculosis (TB) is an infectious disease caused 
by Mycobacterium tuberculosis.1,2  Tuberculosis is 
a serious health problem not only in Indonesia, but 
worldwide.1 In 2003, it is estimated that 9.0 million 
people developed TB and 1.5 million died from the 
disease, and each year it occurs in nearly 9.7 million 
people and claims about 2 million lives worldwide, 
with the highest incidence occur in Asia, South 
America, eastern Europe, and most sub-Saharan 
African countries.1,2
Pulmonary TB is the most common presentation 
of disease. Other than pulmonary TB, there is extra 
pulmonary TB (EPTB). Extra pulmonary TB occurs in 
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20% of all cases of TB in immunocompetent hosts and 
nearly 50% in patient with human immunodeficiency 
virus (HIV).1,2 Extra pulmonary TB means the 
occurrence of TB at sites other than the lung, and 
it can occur in almost any organ system, including 
abdominal organs.2 
Abdominal TB is the sixth most common site 
for EPTB and includes infection anywhere in the 
gastrointestinal tract, peritoneum, and intraabdominal 
organs such as spleen, liver, and pancreas.1,3,4 
Abdominal TB happens in 5-12% of patients with 
TB.1,3 Pancreatic TB is rare even in the endemic 
countries, with incidence report to be less than 4.7% 
worldwide.1,2 However lately cases are increasingly 
reported, probably due to further advancements in 
diagnostic.5 Pancreatic TB first reported in 1944 by 
Auerbach that found only 14 cases with pancreatic 
involvement from 1,656 TB patients.6 
There are two type of pancreatic TB patients, 
first, patients with other organ's involvement as a 
consequence of miliary TB or EPTB with involvement 
of other organs in addition to pancreas; and second, 
primary pancreatic TB which is an isolated involvement 
of pancreas by Mycobacterium tuberculosis in 
the absence of involvement of any other organ or 
previously identified TB. Isolated pancreatic TB is 
rare, and predominantly observed in patient who 
reside in endemic tuberculous zones, patients in areas 
of widespread TB dissemination such as a military 
setting and developing countries, and patients who are 
immunocompromised.1
Diagnosing pancreatic TB is a challenge because of 
its rarity and it has similar symptoms as more common 
pancreatic condition such as pancreatic malignancy.1 
Understanding of pancreatic TB will increased the 
clinical awareness that may guide clinicians to avoid 
unnecessary diagnostic or therapeutic procedures and 
early diagnosis.2,7
PATHOGENESIS
The pathogenesis of pancreatic TB is not known 
for certain because of its rarity, but several possible 
mechanisms for pancreatic involvement in TB have 
been reported: (1) Ingestion of infected material 
from an active pulmonary lesion is on. Ingestion the 
bacilli will gain access to the gastrointestinal tract 
where necrotizing granulomas may develop and 
then spread to the lymphatics affecting any organ 
in the gastrointstinal tract, including hepatobiliary 
and pancreatic tissue; (2) Lymphohematogenous 
dissemination from pulmonary disease, and it seems 
to be the most common mechanism; (3) Reactivation 
of latent tuberculosis in the pancreatic focus; (4) Direct 
spread from an adjacent organ. 1,2,3
The rarity of pancreatic TB occurs due to 
retroperitoneal location of pancreas as well as 
pancreatic enzymes including lipase that interfere 
with the colonization, seeding and proliferation of 
the bacteria.1,3,8 Pancreatic secretions also showed 
to have an antitubercular effect in vitro, thus a 
large intrapancreatic inoculum of Mycobacterium 
tuberculosis is required to cause pancreatic TB.1 
CLINICAL MANIFESTATIONS
We searched PUBMED, Medline and Google 
Scholar database for english language case report of 
pancreatic tuberculosis since January 2016. We only 
included case reports with full text available and 14 
cases were found (Table 1). Of these patients, 7 were 
male (50%) and age range from 16 to 95 years old. 
Only one patient has a pulmonary TB, and it shows 
that pancreatic TB can occur without pulmonary 
involvement. The most common location for pancreatic 
TB has been reported in the head (10- 71.4%), followed 
by the neck (3-21.4%) and the body (2-14,2%). Same 
as our findings, Wintraub et al stated that the most 
common location of pancreatic TB as a mass has been 
reported in the head.6 The most common symptoms 
found is abdominal pain (14-100%), followed by 
weight loss (9-64.3%), loss of apetite (5-25.7%), 
fever (7-35.7%) and jaundice (3-21.4%). Faria et al 
and Shahrokh et al stated that abdominal pain is the 
most common symptoms follows by fever, weight 
loss, appetite loss, and jaundice that were obstructive 
in nature.1,9 Singhai et al stated that the three most 
common presenting complaints were abdominal pain, 
jaundice and weight loss. Pancreatic TB also can 
manifest as night sweats, back pain, and gastrointestinal 
hemorrhage secondary to splenic vein thrombosis.2,10 
Most of the patient will show abdominal tenderness, 
especially upper abdominal on palpation. Patients 
may present with pancreatic mass that is clinically 
indistinguishable from a pancreatic neoplasm.10 Most 
of the patient also had lymphadenopathy.
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DIAGNOSIS
If pancreatic TB is suspected, preliminary testing 
such as tuberculin skin test can be done.2 Tuberculin 
skin test have sensitivity around 58–100% in patients 
with abdominal TB, but has a false-negative rate of 
10%-25%.7 We found that most pancreatic TB can 
shows normal hepatic transaminase (7-70%), normal 
amylase and lipase (5-71.4%), but high bilirubin.5
Pancreatic TB can be classified radiologically 
into 3 groups: mass-forming (with or without 
diffuse pancreatic enlargement), a diffuse form and 
a small nodular form. The mass-forming is the most 
common form that accounts for 94.4% of cases.1 
Ultrasonography (USG) is non-invasive, simple, 
readily available and cost-effective; thus, it is usually 
used as an initial diagnostic tool for patients presenting 
with abdominal pain.1 On USG, pancreatic TB can 
appear as well-defined hypoechoic lesion and shows 
lymph node involvement.3 Around 90.9% patients 
show involvement of lymph node. Shahrokh et al 
stated that, in pancreatic TB, common bile duct and 
the pancreatic duct appear normal in images, even 
if the mass is localized centrally in the head of the 
pancreas. Contrary to pancreatic TB, in pancreatic 
adenocarcinoma the pancreatic duct is dilated in the 
tumors that are positioned centrally in the head region.1 
Other than USG, computed tomography-scan 
(CT-scan) is commonly used and the investigation 
of choice for pathologies of pancreas because of its 
high sensitivity.1  CT findings include hypodense 
lesions with irregular borders usually in the head of 
the pancreas, diffuse enlargement of the pancreas or 
enlarged peripancreatic lymph nodes.10
Magnetic resonance imaging (MRI) findings of 
focal pancreatic TB include sharply delineated mass 
usually located in the pancreatic head, showing 
heterogenous enhancement, hypointense on fat-
suppressed T1-weighted images and show a mixture 
of hypo/hyperintensity on T2-weighted images.10 
It should be noted that there are no pathognomonic 
radiological features of pancreatic TB, and since 
pancreatic TB may present as cystic or solid pancreatic 
masses, abscesses, lymphomas, pseudocysts or acute 
or chronic pancreatitis, cytological or histopathological 
is necessary for the diagnosis of pancreatic 
tuberculosis.1,2,10 Techniques for pancreatic biopsy 
include CT or USG-guided percutaneous biopsy, 
surgical biopsy, or endoscopic ultrasound-(EUS-) 
guided fine needle aspiration (FNA).2 
EUS-guided FNA is known to be quite effective 
in diagnosis and staging of pancreatic carcinoma, 
and emerged as a reliable and cost effective way of 
diagnosing pancreatic TB.3 EUS-FNA has been noted 
to be 76% to 95% accurate for diagnosis of pancreatic 
cancer and 46% for focal inflammation.10 It is also 
preferred for tissue biopsy because of less chances 
of needle tract dissemination especially when the 
mass seems malignant. In EUS-FNA, the samples 
are evaluated by staining, cytology, and culture. The 
microscopic features of tuberculosis are granuloma, 
caseation necrosis (seen in 75-100% of cases) and 
presence of acid fast bacilli (identified in 20-40% 
of cases).1 Bacterial culture, although requiring a 
prolonged incubation, has proven to be the most 
specific diagnostic modality to reveal pancreatic TB.2 
MANAGEMENT 
Once the diagnosis of pancreatic TB has been 
made, standard antituberculin therapy appears to 
be successful in management of this infection.2,4 A 
minimum of 6 months of antituberculin therapy is often 
indicated to achieve resolution of pancreatic lesions 
and alleviation of symptoms.2 Antituberculin therapy 
regimen including isoniazid, rifampicin, pyrazinamide, 
and ethambutol or streptomycin for 6-12 months.1 
Follow-up CT imaging after antituberculin therapy 
may guide clinicians regarding duration of therapy.2 
Pancreatic TB has mortality rate of 10.8%, but death 
can easily avoided with antituberculin treatment.1
However for those patients whose tuberculous 
pancreatic mass is enlarged and causes symptoms 
even after therapy for a reasonable period of time, we 
should consider minimally invasive procedures such 
as endoscopic internal drainage, percutaneous catheter 
drainage or biliary stenting. Percutaneous drainage 
is preferably used in patients with no pancreatic 
duct strictures and pancreatic duct-pseudocyst 
communications and in those with immature or 
infected pseudocysts, or when the patient is at high 
surgical risk, or exhibits malnourishment.1 
CONCLUSION
Pancreatic TB is a rare type of extrapulmonary 
TB. Because of its rarity and have similar symptoms 
as more common pancreatic condition such as 
pancreatic malignancy, diagnosing pancreas TB proven 
to be challenging. The most common symptoms 
is abdominal pain and most of the patients shows 
abdominal tenderness on palpation. Diagnosis of 
pancreatic TB consist of tuberculin skin test, USG, 
CT-Scan, MRI, and biopsy. Due to absence of 
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pathognomonic feature of radiology and various 
form of pancreatic lesions can occur, it is necessary 
to do cytological/histopathological examination using 
material taken with EUS-FNA. Pancreatic TB responds 
well to antituberculin therapy.
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